The Journal of Heart and Lung Transplantation
Volume 29, Issue 6 , Pages 610-615 , June 2010

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension

  • Mark R. Toshner, MB ChB

      Affiliations

    • Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
    • Department of Respiratory, Pulmonary Vascular Diseases Unit, Papworth Hospital NHS Trust, Papworth Everard, Cambridgeshire, UK
    • ,
  • Deepa Gopalan, MB ChB

      Affiliations

    • Department of Respiratory, Pulmonary Vascular Diseases Unit, Papworth Hospital NHS Trust, Papworth Everard, Cambridgeshire, UK
    • ,
  • Jay Suntharalingam, MB ChB

      Affiliations

    • Royal United Hospital, Bath, UK
    • ,
  • Carmen Treacy

      Affiliations

    • Department of Respiratory, Pulmonary Vascular Diseases Unit, Papworth Hospital NHS Trust, Papworth Everard, Cambridgeshire, UK
    • ,
  • Elaine Soon, MB ChB

      Affiliations

    • Department of Respiratory, Pulmonary Vascular Diseases Unit, Papworth Hospital NHS Trust, Papworth Everard, Cambridgeshire, UK
    • ,
  • Karen K. Sheares, MB ChB

      Affiliations

    • Department of Respiratory, Pulmonary Vascular Diseases Unit, Papworth Hospital NHS Trust, Papworth Everard, Cambridgeshire, UK
    • ,
  • Nicholas W. Morrell, MB ChB

      Affiliations

    • Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
    • ,
  • Nicholas Screaton, MB ChB

      Affiliations

    • Department of Respiratory, Pulmonary Vascular Diseases Unit, Papworth Hospital NHS Trust, Papworth Everard, Cambridgeshire, UK
    • ,
  • Joanna Pepke-Zaba, MD

      Affiliations

    • Department of Respiratory, Pulmonary Vascular Diseases Unit, Papworth Hospital NHS Trust, Papworth Everard, Cambridgeshire, UK
    • Corresponding Author InformationReprint requests: Joanna Pepke-Zaba, MD, Pulmonary Vascular Diseases Unit, Papworth Hospital, Papworth Everard, Cambridgeshire CB23 8RE, UK. Telephone: +44-14-80-830541. Fax: +44-14-80-364998

References 

  1. Hoeper MM, Mayer E, Simonneau G, et al. Chronic thromboembolic pulmonary hypertension. Circulation. 2006;113:2011–2020
  2. Riedel M, Stanek V, Widimsky J, et al. Longterm follow-up of patients with pulmonary thromboembolism (Late prognosis and evolution of hemodynamic and respiratory data). Chest. 1982;81:151–158
  3. Suntharalingam J, Treacy CM, Doughty NJ, et al. Long term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest. 2008;134:229–236
  4. Jais X, D'Armini AM, Jansa P, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008;52:2127–2134
  5. Hughes R, Jais X, Suntharalingam J, et al. Current understanding of the role of bosentan in inoperable chronic thromboembolic pulmonary hypertension. Expert Opin Pharmacother. 2006;7:1133–1138
  6. Hoeper MM, Kramm T, Wilkens H, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest. 2005;128:2363–2367
  7. Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347:322–329
  8. Ghofrani HA, Schermuly RT, Rose F, et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2003;167:1139–1141
  9. Nagaya N, Shimizu Y, Satoh T, et al. Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension. Heart. 2002;87:340–345
  10. Suntharalingam J, Hughes RJ, Goldsmith K, et al. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH). Vasc Pharmacol. 2007;46:449–455
  11. Ulrich S, Fischler M, Speich R, et al. Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties. Chest. 2006;130:841–846
  12. Dinh-Xuan AT, Pepke-Zaba J, Cremona G, et al. Endothelial dysfunction in vascular disease. Lancet. 1990;336:1253
  13. Dinh Xuan AT, Higenbottam TW, Clelland C, et al. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol. 1990;99:9–10
  14. Jardim C, Rochitte CE, Humbert M, et al. Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study. Eur Respir J. 2007;29:476–481
  15. Gan CT, Lankhaar JW, Westerhof N, et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest. 2007;132:1906–1912
  16. Pasierski TJ, Starling RC, Binkley PF, et al. Echocardiographic evaluation of pulmonary artery distensibility. Chest. 1993;103:1080–1083
  17. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(suppl S):5S-12
  18. Klepetko W, Mayer E, Sandoval J, et al. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(suppl S):73S-80
  19. Stevens GR, Lala A, Sanz J, et al. Exercise performance in patients with pulmonary hypertension linked to cardiac magnetic resonance measures. J Heart Lung Transplant. 2009;28:899–905
  20. Sanz J, Kariisa M, Dellegrottaglie S, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. J Am Coll Cardiol Cardiovasc Imag. 2009;2:286–295
  21. Condliffe R, Kiely DG, Gibbs JS, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177:1122–1127
  22. Blyth KG, Groenning BA, Mark PB, et al. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J. 2007;29:737–744
  23. Gan CT, McCann GP, Marcus JT, et al. NT-proBNP reflects right ventricular structure and function in pulmonary hypertension. Eur Respir J. 2006;28:1190–1194
  24. Reeves JT, Groves BM, Turkevich D, et al. Right ventricular function in pulmonary hypertension. In:  Weir K,  Reeves JT editor. Pulmonary vascular physiology and pathophysiology. New York: Marcel Dekker; 1989;p. 325–345
  25. Wauthy P, Pagnamenta A, Vassalli F, et al. Right ventricular adaptation to pulmonary hypertension: an interspecies comparison. Am J Physiol Heart Circ Physiol. 2004;286:H1441–H1447
  26. Lankhaar JW, Westerhof N, Faes TJ, et al. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J. 2008;29:1688–1695
  27. Mahapatra S, Nishimura RA, Oh JK, et al. The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr. 2006;19:1045–1050

PII: S1053-2498(09)01535-6

doi: 10.1016/j.healun.2009.12.014

The Journal of Heart and Lung Transplantation
Volume 29, Issue 6 , Pages 610-615 , June 2010

Article Tools

* Image Usage & Resolution